# Safety and Effectiveness of Monovisc® Injection for Osteoarthritis of the Knee

> **NCT00653432** · NA · COMPLETED · sponsor: **Anika Therapeutics, Inc.** · enrollment: 369 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DEVICE:** Monovisc®
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT00653432
- **Lead sponsor:** Anika Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-12
- **Final completion:** 2010-02
- **Target enrollment:** 369 (ACTUAL)
- **Last updated:** 2023-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00653432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00653432, "Safety and Effectiveness of Monovisc® Injection for Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00653432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*